TY027

BIOLOGICAL2 trials

Sponsors

Tychan Pte Ltd.

Conditions

Coronavirus Disease-2019 (COVID-19)

Phase 1

Safety of TY027, a Treatment for COVID-19, in Humans

CompletedNCT04429529

Tychan Pte Ltd.Coronavirus Disease-2019 (COVID-19)

Start: 2020-06-09End: 2021-01-20Updated: 2021-04-08

Phase 3

Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans

TerminatedNCT04649515

Tychan Pte Ltd.Coronavirus Disease-2019 (COVID-19)

Start: 2020-12-04End: 2022-03-04Updated: 2022-03-24